Literature DB >> 22169800

Drugs: More shots on target.

Adrianne Appel.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22169800     DOI： 10.1038/480S40a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  Protein-protein interaction modulators: advances, successes and remaining challenges.

Authors:  Lloyd Mabonga; Abidemi Paul Kappo
Journal:  Biophys Rev       Date:  2019-07-12

Review 2.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29

Review 3.  From bortezomib to other inhibitors of the proteasome and beyond.

Authors:  Daniela Buac; Min Shen; Sara Schmitt; Fathima Rani Kona; Rahul Deshmukh; Zhen Zhang; Christine Neslund-Dudas; Bharati Mitra; Q Ping Dou
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 4.  Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism.

Authors:  Srabani Pal; Ashish Bhattacharjee; Asif Ali; Narayan C Mandal; Subhash C Mandal; Mahadeb Pal
Journal:  J Inflamm (Lond)       Date:  2014-08-09       Impact factor: 4.981

Review 5.  Trial Watch: Proteasomal inhibitors for anticancer therapy.

Authors:  Florine Obrist; Gwenola Manic; Guido Kroemer; Ilio Vitale; Lorenzo Galluzzi
Journal:  Mol Cell Oncol       Date:  2014-12-01

6.  Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma.

Authors:  Nicholas A Gherardin; Liyen Loh; Lorenztino Admojo; Alexander J Davenport; Kelden Richardson; Amy Rogers; Phillip K Darcy; Misty R Jenkins; H Miles Prince; Simon J Harrison; Hang Quach; David P Fairlie; Katherine Kedzierska; James McCluskey; Adam P Uldrich; Paul J Neeson; David S Ritchie; Dale I Godfrey
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

Review 7.  Protein Degradation by E3 Ubiquitin Ligases in Cancer Stem Cells.

Authors:  Macarena Quiroga; Andrea Rodríguez-Alonso; Gloria Alfonsín; Juan José Escuder Rodríguez; Sara M Breijo; Venancio Chantada; Angélica Figueroa
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

8.  Combined approaches for drug design points the way to novel proline racemase inhibitor candidates to fight Chagas' disease.

Authors:  Armand Berneman; Lory Montout; Sophie Goyard; Nathalie Chamond; Alain Cosson; Simon d'Archivio; Nicolas Gouault; Philippe Uriac; Arnaud Blondel; Paola Minoprio
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells.

Authors:  J Cahu; S Bustany; B Sola
Journal:  Cell Death Dis       Date:  2012-12-20       Impact factor: 8.469

Review 10.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.